Your browser doesn't support javascript.
loading
Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series.
Sklar, Bonnie A; Gervasio, Kalla A; Leng, Siyang; Ghosh, Arnab; Chari, Ajai; Wu, Albert Y.
Afiliación
  • Sklar BA; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1183, New York, NY, 10029, USA. bonnie.sklar@icahn.mssm.edu.
  • Gervasio KA; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1183, New York, NY, 10029, USA.
  • Leng S; Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA, 19107, USA.
  • Ghosh A; Department of Medicine, Hematology, and Oncology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA.
  • Chari A; Division of Hematology/Oncology, Columbia University Medical Center, 630 West 168th St., New York, NY, 10032, USA.
  • Wu AY; Department of Medicine, Hematology, and Oncology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA.
BMC Ophthalmol ; 19(1): 110, 2019 May 14.
Article en En | MEDLINE | ID: mdl-31088416
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Blefaritis / Chalazión / Inhibidores de Proteasoma / Bortezomib Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: BMC Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Blefaritis / Chalazión / Inhibidores de Proteasoma / Bortezomib Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: BMC Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2019 Tipo del documento: Article